Baldwin Wealth Partners’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,336
| Closed | -$73.1K | – | 818 |
|
|
2024
Q1 | $73.1K | Hold |
7,336
| – | – | 0.01% | 310 |
|
|
2023
Q4 | $72.3K | Hold |
7,336
| – | – | 0.01% | 325 |
|
|
2023
Q3 | $56.1K | Buy |
7,336
+1,834
| +33% | +$14K | ﹤0.01% | 380 |
|
|
2023
Q2 | $41.1K | Hold |
5,502
| – | – | ﹤0.01% | 436 |
|
|
2023
Q1 | $36.7K | Hold |
5,502
| – | – | ﹤0.01% | 460 |
|
|
2022
Q4 | $42.4K | Hold |
5,502
| – | – | ﹤0.01% | 434 |
|
|
2022
Q3 | $59K | Buy |
5,502
+2,751
| +100% | +$29.5K | 0.01% | 313 |
|
|
2022
Q2 | $22K | Buy |
+2,751
| New | +$22K | ﹤0.01% | 465 |
|
|
2022
Q1 | – | Sell |
-2,751
| Closed | -$47K | – | 693 |
|
|
2021
Q4 | $47K | Buy |
+2,751
| New | +$47K | ﹤0.01% | 354 |
|